Glucagon-like peptide, or GLP-1, is a hormone made in the body that has many metabolic processes
Argente J, Verge CF, Okorie U, Fennoy I, Kelsey MM, Cokkinias C, et al
The most successful outcomes come from people who take a systems-level approach, optimizing nutrition, managing their GLP-1 dosing thoughtfully, supporting their body with evidence-based compounds, and giving the process the time it requires
The 8mg dose hits a sweet spot for most people
[31] The takeaway is vigilance: any GLP-1 user with diabetes especially on combined therapy with SGLT2 inhibitors, who presents with persistent vomiting or reduced oral intake deserves consideration for EDKA